• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,346.17 -303.67
( -0.41%)
Global Indices
Nasdaq
50,746.98 -581.81
(-1.13%)
Dow Jones
7,576.82 -53.96
(-0.71%)
Hang Seng
68,675.29 1,941.05
(2.91%)
Nikkei 225
10,340.87 -32.64
(-0.31%)
Forex
USD-INR
95.08 0.33
(0.35%)
EUR-INR
110.66 0.19
(0.17%)
GBP-INR
127.93 0.48
(0.38%)
JPY-INR
0.60 0.00
(0.18%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0710314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
17.14
103378.79
EPS(TTM)
Face Value()
Div & Yield %
131.92
2
0.8
 

Utique Enterprises reports standalone net loss of Rs 2.46 crore in the March 2026 quarter
May 29,2026
Net Loss of Utique Enterprises reported to Rs 2.46 crore in the quarter ended March 2026 as against net loss of Rs 0.89 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 26.63 crore during the previous quarter ended March 2025.

For the full year,net profit rose 283.67% to Rs 1.88 crore in the year ended March 2026 as against Rs 0.49 crore during the previous year ended March 2025. Sales declined 47.96% to Rs 52.99 crore in the year ended March 2026 as against Rs 101.83 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales026.63 -100 52.99101.83 -48
OPM %01.28 --4.53-0.40 -
PBDT-2.880.54 PL 3.093.29 -6
PBT-2.970.47 PL 2.793.02 -8
NP-2.46-0.89 -176 1.880.49 284